JP2000086480A - Chapped skin treating cosmetic - Google Patents

Chapped skin treating cosmetic

Info

Publication number
JP2000086480A
JP2000086480A JP10254989A JP25498998A JP2000086480A JP 2000086480 A JP2000086480 A JP 2000086480A JP 10254989 A JP10254989 A JP 10254989A JP 25498998 A JP25498998 A JP 25498998A JP 2000086480 A JP2000086480 A JP 2000086480A
Authority
JP
Japan
Prior art keywords
cosmetic
component
present
skin
effect
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP10254989A
Other languages
Japanese (ja)
Inventor
Taiji Nakagawa
泰治 中川
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kanebo Ltd
Original Assignee
Kanebo Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kanebo Ltd filed Critical Kanebo Ltd
Priority to JP10254989A priority Critical patent/JP2000086480A/en
Publication of JP2000086480A publication Critical patent/JP2000086480A/en
Pending legal-status Critical Current

Links

Abstract

PROBLEM TO BE SOLVED: To obtain the subject cosmetic having high safety, very excellent chapped skin curing effect and excellent use feeling by including a phospholipid, a silicone oil and an antiphlogistic. SOLUTION: This cosmetic is obtained by including (A) 0.01-10.0 wt.%, preferably 0.1-5.0 wt.% more preferably 0.2-3.0 wt.% of a phospholipid, (B) 0.01-80.0 wt.%, preferably 0.02-40.0 wt.% of a silicone oil and (C) 0.0001-10.0 wt.%, preferably 0.001-5.0 wt.% of an antiphlogistic. As the component A, phosphatidyl choline, sphingophospholipid or the like is exemplified and its analog or a composition containing it, that is, soybean lecithin, yolk lecithin, its hydride or the like may be used. As the component B, dimethylpolysiloxane, methylphenylpolysiloxane or the like is exemplified. As the component C, a glycyrrhiziate, a glycyrrhiza extract or the like is exemplified.

Description

【発明の詳細な説明】DETAILED DESCRIPTION OF THE INVENTION

【0001】[0001]

【発明の属する技術分野】本発明は、消炎剤による炎症
抑制効果に加え、安全性に優れるリン脂質、シリコン油
(リン脂質で形成されるシリコンエマルション)の被膜
効果により、使用感にも優れ、相乗的に優れた荒れ肌改
善効果を有する化粧料に関する。
BACKGROUND OF THE INVENTION The present invention relates to an anti-inflammatory agent which is effective in suppressing inflammation, and is excellent in feeling of use due to a coating effect of phospholipid and silicone oil (silicone emulsion formed of phospholipid) which is excellent in safety. The present invention relates to a cosmetic having a synergistically excellent effect of improving rough skin.

【0002】[0002]

【従来の技術】従来より、皮膚の荒れ肌、炎症を防ぎ、
皮膚を健常な状態に修繕するために、様々な消炎剤が用
いられてきた。
2. Description of the Related Art Conventionally, rough skin and inflammation have been prevented,
Various anti-inflammatory agents have been used to repair the skin to a healthy state.

【0003】しかしながら、複雑な混合系である化粧料
にこれらの消炎剤を配合しただけでは、炎症抑制効果が
充分に発揮されるものではない。また、一時的には皮膚
を健常な状態に保持することはできても、持続性は乏し
く、荒れ肌を修繕するには至らないという問題もある。
However, the inflammation-suppressing effect is not sufficiently exhibited only by blending these anti-inflammatory agents into cosmetics, which are complex mixed systems. In addition, there is a problem that even though the skin can be temporarily kept in a healthy state, the durability is poor and it is not possible to repair the rough skin.

【0004】一方、従来、リン脂質は安全性の高い天然
由来素材として知られており、化粧料分野においても乳
化剤あるいは保湿剤として、クリーム、乳液、化粧水、
ファンデーション等に使用されている。
[0004] On the other hand, phospholipids are conventionally known as natural materials having high safety. In the cosmetics field, creams, emulsions, lotions, and the like are used as emulsifiers or humectants.
Used for foundations and the like.

【0005】しかしながら、リン脂質を配合した従来の
製剤では炎症抑制効果は得られず、持続的な荒れ肌改善
効果も得られない。
[0005] However, conventional preparations containing phospholipids cannot provide an inflammation-suppressing effect and do not provide a sustained improvement effect on rough skin.

【0006】[0006]

【発明が解決しようとする課題】本発明者は、上記の欠
点を解消すべく鋭意検討を行った結果、リン脂質とシリ
コン油からなるリン脂質シリコンエマルジョンが、炎症
付近に安全性の高い被膜を形成し、消炎剤との相乗効果
により荒れ肌改善効果が格段に向上することを見出し、
本発明を完成した。したがって、本発明の目的とすると
ころは、安全性も高く、非常に優れた荒れ肌改善効果を
持ち、さらに使用感にも優れた新規荒れ肌改善化粧料を
提供するにある。
The present inventors have conducted intensive studies to solve the above-mentioned drawbacks. As a result, the phospholipid silicone emulsion composed of phospholipid and silicone oil formed a highly safe film near inflammation. Formed and found that the synergic effect with the anti-inflammatory agent significantly improves the rough skin improvement effect,
The present invention has been completed. Therefore, an object of the present invention is to provide a novel rough skin improving cosmetic which has high safety, has an extremely excellent effect of improving rough skin, and further has an excellent usability.

【0007】[0007]

【課題を解決するための手段】上述の目的は、成分
(A)としてのリン脂質と成分(B)としてのシリコン
油と成分(C)としての消炎剤を含有することを特徴と
する荒れ肌改善化粧料によって達成される。
The object of the present invention is to improve rough skin characterized by containing a phospholipid as the component (A), a silicone oil as the component (B) and an anti-inflammatory agent as the component (C). Achieved by cosmetics.

【0008】[0008]

【発明の実施の形態】本発明の実施の形態を以下の通り
詳説する。本発明に用いられる成分(A)のリン脂質
は、ホスファチジルコリン、ホスファチジルエタノール
アミン、ホスファチジルセリン、ホスファチジルグリセ
ロール、ホスファチジルイノシトール、スフィンゴリン
脂質等が挙げられ、これらの類似品あるいはこれらを含
有する組成物、すなわち大豆レシチン、卵黄レシチン
等、あるいはそれらの水素添加物も挙げられる。
DESCRIPTION OF THE PREFERRED EMBODIMENTS Embodiments of the present invention will be described in detail as follows. Examples of the phospholipid of the component (A) used in the present invention include phosphatidylcholine, phosphatidylethanolamine, phosphatidylserine, phosphatidylglycerol, phosphatidylinositol, sphingolipids, and the like. Soy lecithin, egg yolk lecithin and the like, and hydrogenated products thereof are also included.

【0009】本発明においては、上記のリン脂質を一種
又は二種以上組み合わせて用いることができる。成分
(A)のリン脂質の配合量としては、化粧料の総量を基
準として0.01〜10.0重量%が好ましく、更に好
ましくは0.1〜5.0重量%であり、最適には0.2
〜3.0重量%である。0.01〜10.0重量%のと
き、剤型の安定性及び感触面で好ましく、更に0.1〜
5.0重量%であるとその傾向が著しく、更に0.2〜
3.0重量%であると更にその傾向が著しい。
In the present invention, one or a combination of two or more of the above phospholipids can be used. The compounding amount of the phospholipid of the component (A) is preferably from 0.01 to 10.0% by weight, more preferably from 0.1 to 5.0% by weight, based on the total amount of the cosmetic, and most preferably. 0.2
~ 3.0% by weight. When the content is 0.01 to 10.0% by weight, the stability and the feel of the dosage form are preferred,
When the content is 5.0% by weight, the tendency is remarkable.
When the content is 3.0% by weight, the tendency is more remarkable.

【0010】本発明で用いられる成分(B)のシリコン
油は、ジメチルポリシロキサン、メチルフェニルポリシ
ロキサン、デカメチルシクロペンタシロキサン、オクタ
メチルシクロテトラシロキサン等が挙げられる。
The silicone oil of the component (B) used in the present invention includes dimethylpolysiloxane, methylphenylpolysiloxane, decamethylcyclopentasiloxane, octamethylcyclotetrasiloxane and the like.

【0011】本発明においては、上記のシリコン油を一
種又は二種以上組み合わせて用いることができる。成分
(B)のシリコン油の配合量としては、化粧料の総量を
基準として0.01〜80.0重量%が好ましく、更に
好ましくは0.02〜40.0重量%が好ましい。0.
01〜80.0重量%のとき被膜形成能及び感触面で好
ましく、更に0.02〜40.0重量%であるとその傾
向が著しい。
In the present invention, the above silicone oils can be used alone or in combination of two or more. The blending amount of the silicone oil as the component (B) is preferably 0.01 to 80.0% by weight, more preferably 0.02 to 40.0% by weight, based on the total amount of the cosmetic. 0.
When the content is from 0.01 to 80.0% by weight, the film-forming ability and the feel are preferable. When the content is from 0.02 to 40.0% by weight, the tendency is remarkable.

【0012】本発明で用いられる成分(C)の消炎剤は
一般的に炎症抑制効果を有する物質であり、グリチルリ
チン酸塩、グリチルレチン酸誘導体等が挙げられ、これ
らを含有する組成物、さらには、甘草抽出末、甘草エキ
ス等も挙げられる。
The anti-inflammatory agent of component (C) used in the present invention is generally a substance having an inflammation-suppressing effect, and includes glycyrrhizinate, glycyrrhetinic acid derivatives and the like. Licorice extract powder, licorice extract and the like are also included.

【0013】本発明においては、上記の消炎剤を一種又
は二種以上組み合わせて用いることができる。成分
(C)の消炎剤の配合量としては、化粧料の総量を基準
として0.0001〜10.0重量%が好ましく、更に
好ましくは0.001〜5.0重量%が好ましい。0.
0001〜10.0重量%のとき炎症抑制効果及び安定
性において好ましく、更に0.001〜5.0重量%で
あるとその傾向が著しい。
In the present invention, the above-mentioned anti-inflammatory agents can be used alone or in combination of two or more. The amount of the anti-inflammatory agent of the component (C) is preferably 0.0001 to 10.0% by weight, more preferably 0.001 to 5.0% by weight, based on the total amount of the cosmetic. 0.
When it is 0001 to 10.0% by weight, it is preferable in terms of the inflammation suppressing effect and stability, and when it is 0.001 to 5.0% by weight, the tendency is remarkable.

【0014】本発明の化粧料には、上述した成分のほか
にも、皮膚外用剤や化粧料に配合される成分、例えば、
油剤、界面活性剤、粉体、顔料、染料、水溶性高分子、
紫外線吸収剤、防腐剤、香料等を、本発明の効果を妨げ
ない範囲内で、適宜配合することができる。
[0014] In addition to the above-mentioned components, the cosmetic of the present invention may further contain components to be incorporated into skin external preparations or cosmetics, for example,
Oils, surfactants, powders, pigments, dyes, water-soluble polymers,
An ultraviolet absorber, a preservative, a fragrance, and the like can be appropriately compounded as long as the effects of the present invention are not impaired.

【0015】本発明は、通常化粧品として用いられるク
リーム、乳液、化粧水、美溶液、ファンデーション等の
剤型に応用できる。
The present invention can be applied to dosage forms such as creams, emulsions, lotions, beauty solutions and foundations which are usually used as cosmetics.

【0016】本発明の化粧料の形態としては、粉末、顆
粒状、固形、半固形、液状、ペースト状、ゲル状等化粧
料に一般に使用されている形態であればいずれでも良い
が、特に液状、ゲル状が好ましい。
The form of the cosmetic of the present invention may be any form generally used in cosmetics such as powder, granule, solid, semi-solid, liquid, paste, gel, etc. And a gel form is preferred.

【0017】本発明の化粧料は、例えば次のようにして
調整することができる。水溶性成分と油溶性成分をそれ
ぞれ80℃で加温溶解し、水溶性成分を油溶性成分に徐
々に添加し、混合した。次いで、攪拌しつつ室温まで冷
却して化粧料を得る。
The cosmetic of the present invention can be prepared, for example, as follows. The water-soluble component and the oil-soluble component were each heated and dissolved at 80 ° C., and the water-soluble component was gradually added to the oil-soluble component and mixed. Next, the mixture is cooled to room temperature with stirring to obtain a cosmetic.

【0018】以下、実施例によって本発明を更に詳細に
説明する。
Hereinafter, the present invention will be described in more detail with reference to examples.

【0019】[0019]

【実施例】実施例に先立って、本発明の評価に用いた
(1)荒れ肌改善効果試験、(2)保湿効果試験(TW
L値低減率)、(3)実用テスト(使用感)の方法につ
いて記載する。
EXAMPLES Prior to the examples, (1) a rough skin improvement effect test and (2) a moisturizing effect test (TW) used in the evaluation of the present invention.
(L value reduction rate) and (3) Method of practical test (feeling of use) are described.

【0020】(1)荒れ肌改善効果試験方法 下脚に、荒れ肌、乾燥肌などを訴える中高年女子被験者
(30〜50才)20名を対象として、4週間連続塗布
した効果を調べた。被験者の左側下脚試験部位に1日1
回約1gの試料を5×10cm面に塗布し、塗布開始前
及び塗布終了3日後の皮膚の状態を表1の皮膚乾燥度の
判定基準により肉眼判定した。なお、右側下脚は試料を
塗布せず対照とした。
(1) Test Method for Improving Rough Skin The effect of continuous application for four weeks was examined on 20 middle-aged and elderly female subjects (30 to 50 years old) who complain of rough or dry skin on the lower leg. One day a day at the subject's left lower leg test site
About 1 g of the sample was applied to a 5 × 10 cm surface, and the skin condition before the start of the application and three days after the end of the application was visually determined according to the criteria for skin dryness shown in Table 1. The lower leg on the right side was used as a control without applying the sample.

【0021】[0021]

【表1】 [Table 1]

【0022】試験前後の試験部位と対照部位の判定結果
を比較し、皮膚乾燥度が2段階以上改善された場合(例
えば、+→−、++→±)を有効、1段階改善された場
合をやや有効、変化がなかった場合を無効とした。試験
結果は有効、やや有効となった被験者の人数で示した。
The judgment results of the test site and the control site before and after the test are compared, and when the degree of dryness of the skin is improved by two or more stages (for example, + →-, ++ → ±), it is effective. Somewhat valid, no change if no change. The test results were indicated by the number of subjects who were effective or slightly effective.

【0023】(2)保湿効果試験(TWL値低減率) 前述の荒れ肌改善効果試験開始前及び終了後の被験者皮
膚を対象とした。4週間連続塗布前及び塗布終了後3日
目にTWL値を測定し、これらの値からTWL値の低減
率(水分保持機能亢進効果)を下記のように算出して保
湿効果を調べた。
(2) Moisturizing effect test (TWL value reduction rate) The subject's skin before and after the start of the above-mentioned rough skin improving effect test was targeted. TWL values were measured before continuous application for 4 weeks and on the 3rd day after the completion of application, and the reduction rate of the TWL value (water retention function enhancing effect) was calculated from these values as described below to examine the moisturizing effect.

【0024】(TWL値の測定法)密閉した皮表上の空
気の一定時間内の湿度変化を電気抵抗に変換して測定す
る方法を用いた。すなわち、被験者の皮表を測定用セル
で密閉し、セルに強制乾燥した空気を通気してセル内を
乾燥空気で充分置換した後、乾燥空気の通気を停止して
その時点でのセル内の相対湿度RHS (%)で求め、次
いで10分間放置して再びセル内の相対湿度RH
10(%)を測定し、この時の湿度変化から次の式により
TWL値(mg/cm2 /hr)を算出した。 TWL値=[(RH10−RHS )×Dt×V×6]/
(S×100) 但し、Dt:測定温度下(t℃)での空気中の飽和水蒸
気の密度(mg/l) V :セルの容積(l) S :測定面積(cm2
(Measurement method of TWL value) A method of converting a change in humidity of air on a closed skin surface within a predetermined time into an electric resistance and measuring the same was used. That is, the skin of the subject is sealed with the measuring cell, forced air is passed through the cell to sufficiently replace the inside of the cell with dry air, and then the ventilation of the dry air is stopped and the inside of the cell at that time is stopped. Determined by relative humidity RH S (%), then left for 10 minutes and again set relative humidity RH in the cell
10 (%) was measured, and a TWL value (mg / cm 2 / hr) was calculated from the change in humidity at this time by the following equation. TWL value = [(RH 10 −RH S ) × Dt × V × 6] /
(S × 100) where Dt: density of saturated water vapor in air at measurement temperature (t ° C.) (mg / l) V: cell volume (l) S: measurement area (cm 2 )

【0025】(TWL値の低減率)TWL値の低減率
は、試料塗布前後のTWL値、TWLA及びTWLBを
次の式に代入して算出した。 TWL値低減率(%)=(1−TWLB/TWLA)×
100 TWLA:試料塗布前のTWL値 TWLB:試料塗布終了後3日目のTWL値 TWL値の低減率が20%以上の場合を「有効」、低減
率が20%未満の場合を「無効」とした。試験結果は、
20人中の「有効」であった被験者の人数で表示した。
(TWL value reduction rate) The TWL value reduction rate was calculated by substituting the TWL values before and after the sample application, TWLA and TWLB into the following equation. TWL value reduction rate (%) = (1−TWLB / TWLA) ×
100 TWLA: TWL value before sample application TWLB: TWL value on the third day after sample application is completed “valid” when the reduction rate of TWL value is 20% or more, and “invalid” when the reduction rate is less than 20% did. The test results are
The number is indicated by the number of subjects who were “effective” out of 20 subjects.

【0026】(3)実用テスト(使用感) 前述の荒れ肌改善効果試験の、終了後3日目の効果を評
価した。試験結果は、皮膚の湿潤性、平滑性、弾力性の
各項目に対して、「皮膚に潤いが生じた」、「皮膚が滑
らかになった」、「皮膚に張りが生じた」と回答した人
数で示した。
(3) Practical test (feeling of use) The effect of the above-mentioned rough skin improvement effect test on the third day after completion was evaluated. In the test results, for each item of skin wettability, smoothness, and elasticity, the respondents answered that "skin was moistened", "skin became smoother", and "skin became tighter" Indicated by the number of people.

【0027】実施例1 表2の組成に基づいて、下記の製法に従い、本発明の荒
れ肌改善化粧料を調整する。
Example 1 Based on the composition shown in Table 2, the rough skin improving cosmetic of the present invention is prepared according to the following production method.

【0028】(調整法)(A)成分と(B)成分をそれ
ぞれ80℃で加温溶解し、(A)成分を(B)成分に徐
々に添加し、混合した。次いで、攪拌しつつ室温まで冷
却して化粧料を得た。
(Adjustment method) The components (A) and (B) were each heated and dissolved at 80 ° C., and the component (A) was gradually added to the component (B) and mixed. Then, the mixture was cooled to room temperature with stirring to obtain a cosmetic.

【0029】[0029]

【表2】 [Table 2]

【0030】実施例2 表3の組成に基づいて、常法により本発明の化粧料を調
整した。
Example 2 Based on the composition shown in Table 3, the cosmetic of the present invention was prepared by a conventional method.

【0031】[0031]

【表3】 [Table 3]

【0032】比較例1 表4の組成に基づいて、常法により本発明の化粧料を調
整した。
Comparative Example 1 Based on the composition shown in Table 4, the cosmetic of the present invention was prepared by a conventional method.

【0033】[0033]

【表4】 [Table 4]

【0034】比較例2 表5の組成に基づいて、常法により本発明の化粧料を調
整した。
Comparative Example 2 Based on the composition shown in Table 5, the cosmetic of the present invention was prepared by a conventional method.

【0035】[0035]

【表5】 [Table 5]

【0036】比較例3 表6の組成に基づいて、常法により、本発明の化粧料を
調整した。
Comparative Example 3 Based on the composition shown in Table 6, the cosmetic of the present invention was prepared by a conventional method.

【0037】[0037]

【表6】 [Table 6]

【0038】実施例と比較例の各化粧料について実施し
た前記各試験の結果を表7に示す。
Table 7 shows the results of the tests performed on the cosmetics of the examples and the comparative examples.

【0039】[0039]

【表7】 [Table 7]

【0040】表7からわかる通り、本発明の実施例1〜
2の化粧料は、本発明の必須条件を満たさない比較例1
〜3の化粧料と比べて、諸特性の全てに亘って優れてい
た。
As can be seen from Table 7, Examples 1 to 3 of the present invention are shown.
Comparative Example 1 does not satisfy the essential conditions of the present invention.
As compared with the cosmetics of Nos. 1 to 3, all the properties were excellent.

【発明の効果】【The invention's effect】

【0041】以上記載のように、本発明の荒れ肌改善化
粧料は、皮膚の水分保持機能を持続的に亢進、維持する
効果が高く、相乗効果により荒れ肌改善効果を持ち、実
用上の使用感にも優れた荒れ肌改善化粧料を提供するこ
とは明らかである。
As described above, the rough skin improving cosmetic of the present invention has a high effect of continuously enhancing and maintaining the moisture retention function of the skin, has a rough skin improving effect by a synergistic effect, and has a practical use feeling. It is clear that it also provides excellent rough skin improving cosmetics.

Claims (1)

【特許請求の範囲】[Claims] 【請求項1】 成分(A)としてのリン脂質と成分
(B)としてのシリコン油と成分(C)としての消炎剤
を含有することを特徴とする荒れ肌改善化粧料。
1. A rough skin improving cosmetic comprising a phospholipid as the component (A), a silicone oil as the component (B), and an anti-inflammatory agent as the component (C).
JP10254989A 1998-09-09 1998-09-09 Chapped skin treating cosmetic Pending JP2000086480A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP10254989A JP2000086480A (en) 1998-09-09 1998-09-09 Chapped skin treating cosmetic

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP10254989A JP2000086480A (en) 1998-09-09 1998-09-09 Chapped skin treating cosmetic

Publications (1)

Publication Number Publication Date
JP2000086480A true JP2000086480A (en) 2000-03-28

Family

ID=17272671

Family Applications (1)

Application Number Title Priority Date Filing Date
JP10254989A Pending JP2000086480A (en) 1998-09-09 1998-09-09 Chapped skin treating cosmetic

Country Status (1)

Country Link
JP (1) JP2000086480A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009110205A1 (en) * 2008-03-04 2009-09-11 ナガセケムテックス株式会社 Agent for increasing the quantity of hyaluronic acid

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009110205A1 (en) * 2008-03-04 2009-09-11 ナガセケムテックス株式会社 Agent for increasing the quantity of hyaluronic acid
JP5561614B2 (en) * 2008-03-04 2014-07-30 ナガセケムテックス株式会社 Hyaluronic acid extender

Similar Documents

Publication Publication Date Title
KR20090017336A (en) Cosmetic composition containing liquid crystal complex for enhancing moisturizing effect on the skin and for reducing skin roughness
JPS62175415A (en) Skin cosmetic
JPH07116010B2 (en) Cosmetics
JPS60116618A (en) Cosmetic
JPH09291013A (en) Skin cosmetic material
JPH0366604A (en) Dermal cosmetic
KR20080038812A (en) A cosmetic of sheet-type containing unsoluble material stably in a low viscosity level state
JPS62169711A (en) Skin cosmetic
JP2000086480A (en) Chapped skin treating cosmetic
JPH0672841A (en) Gel-like massage agent and pack agent
JPS60161912A (en) Skin cosmetic
JPS6150908A (en) Skin cosmetic
JP2002275027A (en) Cosmetic and cosmetic impregnated in nonwoven fabric
KR100569304B1 (en) Color cosmetic composition of powdery type
JPH06219936A (en) Skin cosmetic
JP3532713B2 (en) Skin cosmetics
JPS62298509A (en) Skin cosmetic
JP3441166B2 (en) Anti-aging skin cosmetics
JPS60116616A (en) Cosmetic
EP1093800B1 (en) Cosmetic composition
JPS60116617A (en) Cosmetic
KR100669637B1 (en) Water-soluble gel composition and cosmetic composition containing the gel composition for moisturizing
JPS62192307A (en) Skin cosmetic
JPH06287106A (en) Skin cosmetic
JPS59176203A (en) Skin cosmetic

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20040701

A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A711

Effective date: 20040805

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20040806

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20050201

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20050802

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20051003

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20051122

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20060123

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20060228

A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A711

Effective date: 20060328